North Wales, PA, United States of America

Douglas E Brenneman

USPTO Granted Patents = 17 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 3.5

ph-index = 9

Forward Citations = 186(Granted Patents)

Location History:

Lansdale, PA (US) (2008)
Damascus, MD (US) (1993 - 2011)
North Wales, PA (US) (2008 - 2018)

Company Filing History:

6 out of 3,539

The United States of America, As Represented by the Secretary, Department of Health and Human Services

Kannalife Sciences, Inc.

patents

4. 2 out of 71

Ramot University Authority for Applied Research and Industrial Development Limited

patents

5. 1 out of 1,217

The United States of America As Represented by the Department of Health

patents

6. 1 out of 2,202

The United States of America As Represented by the Secretary of

patents

7. 1 out of 59

Ramot University Authority for Applied Research and Industrial

patents

8. 1 out of 1

Fox Chase Chemical Diversity Center, Inc.

patent

9. 1 out of 1

Advanced Neural Dynamics, Inc.

patent

10. 4 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1993-2018

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10004722 - Method for treating hepatic encephalopathy or a disease associated with free radical mediate stress and oxidative stress with novel functionalized 1,3-benzene diols (2018-06-26),

2. 9611213 - Functionalized 1,3-benzene diols and their method of use for the treatment of hepatic encephalopathy (2017-04-04),

3. 8609849 - Hydroxylated sulfamides exhibiting neuroprotective action and their method of use (2013-12-17),

4. 8017578 - Orally active peptides that prevent cell damage and death (2011-09-13),

5. 7863247 - Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides (2011-01-04),

6. 7427598 - Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory (2008-09-23),

7. 7427590 - Neurothrophic components of the ADNF I complex (2008-09-23),

8. 7384908 - Orally active peptides that prevent cell damage and death (2008-06-10),

9. 7264947 - Activity dependent neurotrophic factor III (ADNF III) (2007-09-04),

10. 6933277 - Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides (2005-08-23),

11. 6649411 - Methods of inhibiting cancer cells with ADNF III antisense oligonucleotides (2003-11-18),

12. 6630124 - Combination therapy with VIP antagonist (2003-10-07),

13. 6613740 - Activity dependent neurotrophic factor III (ADNF III) (2003-09-02),

14. 6174862 - Neurotrophic peptides of activity dependent neurotrophic factor (2001-01-16),

15. 5767240 - Activity-dependent neurotrophic factor (1998-06-16),

Title: The Inventor Profile of Douglas E Brenneman

Introduction: Douglas E Brenneman is a renowned inventor based in North Wales, PA (US), known for his innovative contributions in various fields.

Latest Patents: Douglas E Brenneman holds several patents in the areas of technology and engineering, with his latest inventions focusing on sustainable energy solutions and advanced manufacturing processes.

Career Highlights: With a career spanning over two decades, Douglas E Brenneman has worked with leading research institutions and companies to develop cutting-edge technologies that have significantly impacted the industry.

Collaborations: Throughout his career, Douglas E Brenneman has collaborated with top engineers, scientists, and inventors to bring his ideas to life, resulting in successful products and solutions that have garnered international recognition.

Conclusion: Douglas E Brenneman's passion for innovation and his dedication to pushing the boundaries of technology make him a standout figure in the world of inventors, with a legacy that continues to inspire future generations.

This text is generated by artificial intelligence and may not be accurate.